Cao Receives R35 Outstanding Investigator Grant

November 16, 2017

Yanguang “Carter” Cao, Ph.D., has received a R35 Outstanding Investigator Grant worth $1.85 million over five years from the National Institute of General Medical Sciences to create a platform to optimize antibody-based therapy. “Therapeutic antibodies have achieved great success in … Continued

UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop

October 25, 2017

UNC Catalyst Hosts NIH/NCATS Assay Guidance Workshop The UNC Catalyst for Rare Diseases, together with Promega, sponsored an NIH/NCATS assay guidance workshop for high-throughput screening and lead discovery on Monday, October 23. Forty-nine scientists from academia and the pharmaceutical and … Continued